You are here

  • Home
  • Archive
  • Volume 81, Issue 2
  • Response to: ‘Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG4-related disease’ by Simpson et al’ by Ebbo et al

Article metrics

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG4-related disease’ by Simpson et al’ by Ebbo et al
Free

 

Online download statistics by month:

Online download statistics by month: March 2020 to April 2022

AbstractFullPdf
Mar 202032031775
Apr 202021821436
May 2020353113
Jun 2020252510
Jul 2020262511
Aug 2020161610
Sep 202032265
Oct 2020252511
Nov 202017178
Dec 2020393612
Jan 2021555513
Feb 2021282814
Mar 2021343317
Apr 2021292914
May 2021686311
Jun 2021424215
Jul 2021292710
Aug 2021363613
Sep 2021242410
Oct 2021363420
Nov 2021363610
Dec 202191904
Jan 202235035219
Feb 202215915526
Mar 2022464618
Apr 2022565718
Total18721839423